WHO WE ARE
BDI, a 501(c)(3) nonprofit organization located in San Diego, California, focuses on addressing the social, emotional, and psychological barriers to living a long and healthy life with diabetes. To better understand and overcome these obstacles, BDI is actively engaged in research examining the psychological aspects of diabetes and evaluating innovative behavioral interventions. In addition, BDI directly offers an array of unique, behaviorally-oriented products and services for: people with type 1 diabetes; people with type 2 diabetes; parents of children and teens with diabetes; spouses and partners of people with diabetes; and interested health care professionals. Products and services include print materials; online courses and modules, face-to-face workshops and seminars, professional training programs, and an online library of resources.
We invite you to explore the resources available to you from BDI. We also welcome your suggestions for additional resources that might be added to our web site. Thank you!
ADA 77th Scientific Sessions, San Diego, CA.
Save the Date! Click here for more information and to register.
June 9-11, 2017
5K@ADA, San Diego, 2017.
Help set the pace for changing diabetes by running or walking the 5K route in San Diego. Click here for more information and to register.
June 11, 2017
BDI’s Monthly Update for February 2017:
The clinical side: We’ve just completed another successful two-day training program for healthcare professionals. As usual, it was a full house, and there was a long waiting list. We had participants from all over the United States and from Australia and Brazil. And now we are already in early planning for more programs later in 2017. Stay tuned for details!
On the research side: Among our publications in January, we are most proud that BDI staff were co-authors on two important papers on the use of CGM (continuous glucose monitoring) in people with type 1 diabetes who are on multiple daily injections. The results, published in the Journal of the American Medical Association (JAMA) were quite promising, indicating that CGM isn’t just for pump users; it can potentially be of great benefit to all people with type 1 diabetes. You can view the two abstracts here and here.